Pfizer covid shot 80 percent effective in young kids, early data shows
Companies, agencies, institutions, etc
Pfizer
BioNTech
Pfizer and
the Food and Drug Administration
Johns Hopkins Bloomberg School of Public Health
Omicron
Moderna
A Centers for Disease Control and Prevention
FDA
Pfizer-BioNTech
Baylor College of Medicine
the Pfizer-BioNTech
Pfizer and BioNTech
Emory University’s
Rollins School of Public Health
CDC
White House
ABC News’s
PCR
People
Kawsar Talaat
Flor Munoz
David Benkeser
Ashish Jha
Mask
Groups
German
Americans
covid-19
Physical locations
No matching tags
Places
No matching tags
Locations
No matching tags
Events
This Week
Summary
For the Omicron variant, a third dose is necessary for optimal protection.”Federal officials are already reviewing the pediatric vaccine from biotechnology company Moderna, a two-shot regimen that was 51 percent effective in preventing illness in children between 6 months and 2 years old, and 37 percent effective in children 2 to 5 years old.Regulators previously set aside three dates for outside vaccine experts to meet and debate the vaccines for young children: June 8, 21 and 22.
As said here by Carolyn Y. Johnson